Triple

T7392985
Position Surface form Disambiguated ID Type / Status
Subject George Church E170546 entity
Predicate coFounded P104 FINISHED
Object Veritas Genetics
Veritas Genetics is a biotechnology company that offers whole-genome sequencing and interpretation services for consumers and clinicians.
 E661989 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Veritas Genetics | Statement: [George Church, coFounded, Veritas Genetics]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Veritas Genetics
Context triple: [George Church, coFounded, Veritas Genetics]
  • A. Horizon Discovery
    Horizon Discovery is a biotechnology company specializing in gene editing and cell-based research tools used for drug discovery and development.
  • B. Myriad Genetics
    Myriad Genetics is a biotechnology company best known for developing and commercializing genetic tests, particularly for assessing inherited cancer risk.
  • C. Yale Center for Genomic Health
    The Yale Center for Genomic Health is a research and clinical center at Yale focused on advancing precision medicine through genomic analysis, interpretation, and integration into patient care.
  • D. Cambridge Epigenetix
    Cambridge Epigenetix is a biotechnology company specializing in epigenetic sequencing technologies that enable more detailed and cost-effective analysis of DNA modifications for research and clinical applications.
  • E. NewLink Genetics
    NewLink Genetics is a biopharmaceutical company known for developing immuno-oncology therapies and infectious disease vaccines, including holding rights to the rVSV-ZEBOV Ebola vaccine candidate.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Veritas Genetics
Triple: [George Church, coFounded, Veritas Genetics]
Generated description
Veritas Genetics is a biotechnology company that offers whole-genome sequencing and interpretation services for consumers and clinicians.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Veritas Genetics
Target entity description: Veritas Genetics is a biotechnology company that offers whole-genome sequencing and interpretation services for consumers and clinicians.
  • A. Horizon Discovery
    Horizon Discovery is a biotechnology company specializing in gene editing and cell-based research tools used for drug discovery and development.
  • B. Myriad Genetics
    Myriad Genetics is a biotechnology company best known for developing and commercializing genetic tests, particularly for assessing inherited cancer risk.
  • C. Yale Center for Genomic Health
    The Yale Center for Genomic Health is a research and clinical center at Yale focused on advancing precision medicine through genomic analysis, interpretation, and integration into patient care.
  • D. Cambridge Epigenetix
    Cambridge Epigenetix is a biotechnology company specializing in epigenetic sequencing technologies that enable more detailed and cost-effective analysis of DNA modifications for research and clinical applications.
  • E. NewLink Genetics
    NewLink Genetics is a biopharmaceutical company known for developing immuno-oncology therapies and infectious disease vaccines, including holding rights to the rVSV-ZEBOV Ebola vaccine candidate.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c68a5e2c9081909e713ce866e0060a completed March 27, 2026, 1:47 p.m.
NER Named-entity recognition batch_69c6f224790c819099ceb7c7ac8d00f6 completed March 27, 2026, 9:09 p.m.
NED1 Entity disambiguation (via context triple) batch_69c810f82ba08190919924b0994a2eee completed March 28, 2026, 5:33 p.m.
NEDg Description generation batch_69c811f1fe3c8190a591186b19044b5f completed March 28, 2026, 5:37 p.m.
NED2 Entity disambiguation (via description) batch_69c812c1e9d08190b0e7f052d87011b9 completed March 28, 2026, 5:41 p.m.
Created at: March 27, 2026, 3:09 p.m.